Article Versions Notes

Zhuang Z, Zhou J, Qiu M, Li J, Lin Z, Yi H, Liu X, Huang C, Tang B, Liu B, et al. The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment. Cancers. 2024; 16(4):832. https://doi.org/10.3390/cancers16040832

Zhuang, Zhan, Jinglin Zhou, Minglian Qiu, Jiamian Li, Zhuangheng Lin, Huihan Yi, Xuerong Liu, Changyu Huang, Binghua Tang, Bo Liu, and et al. 2024. "The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment" Cancers 16, no. 4: 832. https://doi.org/10.3390/cancers16040832

Zhuang, Z., Zhou, J., Qiu, M., Li, J., Lin, Z., Yi, H., Liu, X., Huang, C., Tang, B., Liu, B., & Li, X. (2024). The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment. Cancers, 16(4), 832. https://doi.org/10.3390/cancers16040832